Title | Chromatin Remodeling of Colorectal Cancer Liver Metastasis is Mediated by an HGF-PU.1-DPP4 Axis. |
Publication Type | Journal Article |
Year of Publication | 2021 |
Authors | L Wang, E Wang, Prado J Balcazar, Z Wu, K Xiang, Y Wang, Q Huang, M Negrete, K-Y Chen, W Li, Y Fu, A Dohlman, R Mines, L Zhang, Y Kobayashi, T Chen, G Shi, JP Shen, S Kopetz, PR Tata, V Moreno, C Gersbach, G Crawford, D Hsu, E Huang, P Bu, and X Shen |
Journal | Adv Sci (Weinh) |
Volume | 8 |
Issue | 19 |
Start Page | e2004673 |
Date Published | 10/2021 |
Abstract | Colorectal cancer (CRC) metastasizes mainly to the liver, which accounts for the majority of CRC-related deaths. Here it is shown that metastatic cells undergo specific chromatin remodeling in the liver. Hepatic growth factor (HGF) induces phosphorylation of PU.1, a pioneer factor, which in turn binds and opens chromatin regions of downstream effector genes. PU.1 increases histone acetylation at the DPP4 locus. Precise epigenetic silencing by CRISPR/dCas9KRAB or CRISPR/dCas9HDAC revealed that individual PU.1-remodeled regulatory elements collectively modulate DPP4 expression and liver metastasis growth. Genetic silencing or pharmacological inhibition of each factor along this chromatin remodeling axis strongly suppressed liver metastasis. Therefore, microenvironment-induced epimutation is an important mechanism for metastatic tumor cells to grow in their new niche. This study presents a potential strategy to target chromatin remodeling in metastatic cancer and the promise of repurposing drugs to treat metastasis. |
DOI | 10.1002/advs.202004673 |
Short Title | Adv Sci (Weinh) |